Detalles de la búsqueda
1.
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.
Mol Cell
; 71(4): 606-620.e7, 2018 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30118680
2.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer
; 130(10): 1747-1757, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236702
3.
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
Oncologist
; 28(10): 845-855, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37318349
4.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
; 250(5): 667-684, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32129476
5.
Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.
Breast Cancer Res Treat
; 171(2): 283-293, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29858753
6.
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis.
PLoS Med
; 13(12): e1002193, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27959926
7.
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.
Mod Pathol
; 29(4): 330-46, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26916073
8.
Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 29(7): 1344-1359, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689560
9.
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy.
Res Sq
; 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168324
10.
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.
Cancer Res
; 83(19): 3284-3304, 2023 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37450351
11.
Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer.
Breast Cancer Res
; 14(3): R72, 2012 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22559056
12.
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.
J Clin Oncol
; 39(23): 2539-2551, 2021 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092112
13.
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.
Breast Cancer Res Treat
; 121(2): 301-9, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19603265
14.
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state.
Sci Transl Med
; 11(488)2019 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30996079
15.
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.
Clin Cancer Res
; 13(1): 228-33, 2007 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17200359
16.
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer.
Nat Commun
; 9(1): 5079, 2018 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30498242
17.
A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis.
NPJ Breast Cancer
; 4: 9, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29736411
18.
Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.
Hum Pathol
; 77: 121-129, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29689244
19.
FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition.
Sci Rep
; 6: 23070, 2016 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27064522
20.
Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.
JAMA Oncol
; 2(4): 508-16, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26720612